UBS Group AG Has $7.03 Million Stake in Tilray Brands, Inc. $TLRY

UBS Group AG lowered its position in shares of Tilray Brands, Inc. (NASDAQ:TLRY) by 72.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 778,593 shares of the company’s stock after selling 1,997,852 shares during the quarter. UBS Group AG’s holdings in Tilray Brands were worth $7,031,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of TLRY. Tidal Investments LLC grew its holdings in Tilray Brands by 15.0% during the second quarter. Tidal Investments LLC now owns 28,971,835 shares of the company’s stock valued at $12,006,000 after purchasing an additional 3,776,410 shares during the period. Millennium Management LLC grew its holdings in Tilray Brands by 281.0% during the third quarter. Millennium Management LLC now owns 4,942,319 shares of the company’s stock valued at $8,550,000 after purchasing an additional 3,645,060 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Tilray Brands during the third quarter valued at approximately $5,813,000. Ausdal Financial Partners Inc. acquired a new position in Tilray Brands during the second quarter valued at approximately $939,000. Finally, Scientech Research LLC acquired a new position in Tilray Brands during the third quarter valued at approximately $1,748,000. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Brands Stock Performance

Shares of TLRY opened at $5.21 on Wednesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79. Tilray Brands, Inc. has a twelve month low of $3.51 and a twelve month high of $23.20. The firm’s 50 day moving average price is $6.46 and its two-hundred day moving average price is $8.29. The firm has a market cap of $607.23 million, a P/E ratio of -0.38 and a beta of 1.94.

Tilray Brands (NASDAQ:TLRY) last announced its quarterly earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.10). Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. The company had revenue of $206.73 million during the quarter, compared to the consensus estimate of $201.35 million. During the same period in the previous year, the firm posted ($0.87) EPS. On average, analysts forecast that Tilray Brands, Inc. will post -0.58 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on TLRY shares. Roth Mkm upgraded shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price objective for the company in a report on Thursday, April 2nd. Zacks Research raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 11th. Canaccord Genuity Group assumed coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They issued a “hold” rating on the stock. ATB Cormark Capital Markets cut their price target on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 2nd. Finally, Wall Street Zen raised shares of Tilray Brands from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. Three investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $11.50.

Insider Activity at Tilray Brands

In other news, Director David G. Hopkinson sold 33,556 shares of the business’s stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total value of $232,878.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.84% of the stock is currently owned by corporate insiders.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.